| Product Code: ETC12838725 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Influenza Vaccines Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Influenza Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 China Influenza Vaccines Market - Industry Life Cycle |
3.4 China Influenza Vaccines Market - Porter's Five Forces |
3.5 China Influenza Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 China Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
3.7 China Influenza Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 China Influenza Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 China Influenza Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination in China |
4.2.2 Government initiatives to promote vaccination and improve access to vaccines |
4.2.3 Growing elderly population in China, who are more susceptible to influenza |
4.3 Market Restraints |
4.3.1 Limited public healthcare infrastructure in rural areas, affecting vaccine distribution |
4.3.2 Vaccine hesitancy among certain segments of the population |
4.3.3 Presence of counterfeit or substandard vaccines in the market |
5 China Influenza Vaccines Market Trends |
6 China Influenza Vaccines Market, By Types |
6.1 China Influenza Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 China Influenza Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 China Influenza Vaccines Market Revenues & Volume, By Inactivated Influenza Vaccine (IIV), 2021 - 2031F |
6.1.4 China Influenza Vaccines Market Revenues & Volume, By Live Attenuated Influenza Vaccine (LAIV), 2021 - 2031F |
6.1.5 China Influenza Vaccines Market Revenues & Volume, By Recombinant Influenza Vaccine, 2021 - 2031F |
6.2 China Influenza Vaccines Market, By Strain Type |
6.2.1 Overview and Analysis |
6.2.2 China Influenza Vaccines Market Revenues & Volume, By Trivalent Vaccines, 2021 - 2031F |
6.2.3 China Influenza Vaccines Market Revenues & Volume, By Quadrivalent Vaccines, 2021 - 2031F |
6.3 China Influenza Vaccines Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 China Influenza Vaccines Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 China Influenza Vaccines Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 China Influenza Vaccines Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 China Influenza Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 China Influenza Vaccines Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4.3 China Influenza Vaccines Market Revenues & Volume, By Nasal Spray, 2021 - 2031F |
7 China Influenza Vaccines Market Import-Export Trade Statistics |
7.1 China Influenza Vaccines Market Export to Major Countries |
7.2 China Influenza Vaccines Market Imports from Major Countries |
8 China Influenza Vaccines Market Key Performance Indicators |
8.1 Percentage increase in influenza vaccine coverage rates among target populations |
8.2 Number of government-supported vaccination campaigns conducted annually |
8.3 Average time taken from vaccine production to distribution in key regions |
8.4 Rate of reported adverse events following influenza vaccination |
8.5 Number of new entrants or expansions in the influenza vaccine market in China |
9 China Influenza Vaccines Market - Opportunity Assessment |
9.1 China Influenza Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 China Influenza Vaccines Market Opportunity Assessment, By Strain Type, 2021 & 2031F |
9.3 China Influenza Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 China Influenza Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 China Influenza Vaccines Market - Competitive Landscape |
10.1 China Influenza Vaccines Market Revenue Share, By Companies, 2024 |
10.2 China Influenza Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here